After nearly three years of complex negotiations, member nations of the World Health Organization (WHO) have reached a preliminary consensus on how to collectively address future pandemics. Described as an agreement “in principle,” the accord represents a significant breakthrough in global health cooperation, according to the co-chair of the WHO’s negotiating body, who shared the update with Agence France-Presse (AFP). Although the WHO has not yet released an official statement, the development marks a critical step toward more unified pandemic response strategies.

The urgency behind this accord stems from the lessons learned during the COVID-19 pandemic, which revealed major flaws in global preparedness and response. Countries struggled with delayed communication, fragmented supply chains, and unequal access to medical resources, underscoring the need for stronger coordination. This new agreement aims to correct those deficiencies by laying out a framework for international collaboration both before and during future outbreaks.

Central to the proposed pact are measures to enhance early-warning systems, streamline data sharing, and ensure equitable access to vaccines, medicines, and protective equipment. The accord also promotes financial solidarity, emphasizing joint investments in preparedness infrastructure. Though the final details are still being refined, the intent is clear: to build a more resilient global health architecture that can act swiftly and equitably in the face of emerging threats.

However, one notable absence casts a shadow over the deal — that of the United States. In February, President Donald Trump signed an executive order that withdrew the U.S. from the WHO and halted its participation in the treaty talks. The decision, seen by many as a retreat from global health leadership, has raised concerns about the agreement’s long-term strength and influence, especially without backing from one of the world’s largest funders of health initiatives.

Despite this, the agreement is not yet finalized. Remaining debates include issues of national sovereignty, distribution of financial responsibilities, and intellectual property rights related to vaccines and medical technologies. These unresolved areas must be addressed before the pact can be officially adopted and put into action.

Still, the accord marks a hopeful turning point. With the scars of COVID-19 still vivid, there is growing political momentum to prevent a similar crisis from overwhelming the world again. If the agreement becomes a binding treaty and receives full international support, it could redefine how nations cooperate in the face of global health emergencies — creating a more united, prepared, and equitable future for global public health.